Table 5.
Relative risk of second primary cancer for any first primary cancer by type of second primary cancer and sex
| Males | Females | |||||||
|---|---|---|---|---|---|---|---|---|
| Second primary cancer | O | E | SIR | 95%CI | O | E | SIR | 95%CI |
| Oral Cavity & Pharynx | 1136 | 449.60 | 2.53 | (2.38–2.68) | 429 | 189.05 | 2.27 | (2.05–2.49) |
| Oesophagus | 566 | 293.21 | 1.93 | (1.76–2.10) | 219 | 96.60 | 2.27 | (1.95–2.59) |
| Stomach | 670 | 528.41 | 1.27 | (1.17–1.37) | 386 | 299.80 | 1.29 | (1.15–1.42) |
| Colorectal | 2430 | 2066.81 | 1.18 | (1.13–1.22) | 1923 | 1470.15 | 1.31 | (1.25–1.37) |
| Liver & Intrahepatic Bile Ducts | 576 | 453.56 | 1.27 | (1.16–1.38) | 192 | 137.66 | 1.39 | (1.19–1.60) |
| Pancreas | 669 | 490.60 | 1.36 | (1.26–1.47) | 598 | 469.70 | 1.27 | (1.17–1.38) |
| Larynx | 317 | 179.31 | 1.77 | (1.56–1.97) | 50 | 26.04 | 1.92 | (1.31–5.53) |
| Lung | 3551 | 2262.39 | 1.57 | (1.52–1.62) | 1601 | 891.66 | 1.80 | (1.71–1.88) |
| Skin Melanoma | 926 | 670.74 | 1.38 | (1.29–1.47) | 736 | 513.03 | 1.43 | (1.33–1.54) |
| Breast female | – | – | – | – | 2597 | 3515.70 | 0.74 | (0.71–0.77) |
| Cervix Uteri | – | – | – | – | 125 | 152.49 | 0.82 | (0.66–0.98) |
| Corpus Uteri & NOS | – | – | – | – | 876 | 674.95 | 1.30 | (1.21–1.39) |
| Ovary | – | – | – | – | 530 | 437.46 | 1.21 | (1.10–1.32) |
| Prostate | 3694 | 5486.76 | 0.67 | (0.65–0.70) | – | – | – | – |
| Testis | 36 | 49.08 | 0.73 | (0.45–1.02) | – | – | – | – |
| Kidney | 537 | 396.46 | 1.35 | (1.23–1.47) | 275 | 196.64 | 1.40 | (1.22–1.57) |
| Bladder | 1053 | 855.25 | 1.23 | (1.16–1.31) | 334 | 238.59 | 1.40 | (1.24–1.56) |
| Brain & Central Nerves | 242 | 184.26 | 1.31 | (1.14–1.49) | 161 | 139.94 | 1.15 | (0.96–1.34) |
| Thyroid | 143 | 60.76 | 2.35 | (1.93–2.77) | 271 | 156.18 | 1.74 | (1.52–1.95) |
| Hodgkin Lymphoma | 67 | 39.21 | 1.71 | (1.25–2.17) | 56 | 28.16 | 1.99 | (1.39–2.58) |
| Non Hodgkin Lymphoma | 733 | 539.77 | 1.36 | (1.26–1.46) | 568 | 440.42 | 1.29 | (1.18–1.40) |
| Multiple Myeloma | 291 | 231.10 | 1.26 | (1.11–1.41) | 196 | 188.29 | 1.04 | (0.88–1.20) |
| Leukaemia | 590 | 428.02 | 1.38 | (1.26–1.49) | 472 | 283.12 | 1.67 | (1.51–1.82) |
| All Cancers | 18,811 | 16,827.19 | 1.18 | (1.16–1.19) | 13,982 | 11,631.97 | 1.20 | (1.18–1.22) |
O: number of observed cases
E: number of expected cases
SIR: standardized incidence ratio
95%CI: 95% confidence intervals